Shopping Cart
Remove All
Your shopping cart is currently empty
PDL-241 is a humanized monoclonal antibody targeting SLAMF7 (also known as CD319 or CS1), which is highly expressed on multiple myeloma cells and natural killer (NK) cells. It exerts anti-tumor effects by directly inducing apoptosis, mediating ADCC effects, and boosting anti-tumor immunity through NK cell activation, making it widely used in research on targeted therapies for hematological malignancies.

| Description | PDL-241 is a humanized monoclonal antibody targeting SLAMF7 (also known as CD319 or CS1), which is highly expressed on multiple myeloma cells and natural killer (NK) cells. It exerts anti-tumor effects by directly inducing apoptosis, mediating ADCC effects, and boosting anti-tumor immunity through NK cell activation, making it widely used in research on targeted therapies for hematological malignancies. |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Uniprot ID | |
| Target | SLAMF7/CS1 |
| Isotype | IgG1 |
| Storage | store at low temperature | Lyophilized powder: -20~-80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.